Cargando…

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production

Detalles Bibliográficos
Autores principales:	Gentilcore, Giusy, Pico de Yago, Coaña, Poschke, Isabel, Mao, Yumeng, Nyström, Maria, Hansson, Johan, Masucci, Giuseppe V, Kiessling, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108882/ http://dx.doi.org/10.1186/1479-5876-12-S1-O9

Ejemplares similares

Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
por: Pico de Coaña, Yago, et al.
Publicado: (2015)

Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
por: Pico de Coaña, Yago, et al.
Publicado: (2014)

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
por: de Coaña, Yago Pico, et al.
Publicado: (2017)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
por: de Boniface, Jana, et al.
Publicado: (2012)

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates
por: Pico de Coaña, Yago, et al.
Publicado: (2020)

Combination therapy with ipilimumab and electrochemotherapy: preliminary efficacy results and correlation with immunological parameters
por: Simeone, Ester, et al.
Publicado: (2014)

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma
por: Melief, Jeroen, et al.
Publicado: (2020)

Counteracting CAR T cell dysfunction
por: Poorebrahim, Mansour, et al.
Publicado: (2021)

Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
por: Dean, Matthew J., et al.
Publicado: (2021)

Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood
por: Rad Pour, Soudabeh, et al.
Publicado: (2021)

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
por: Rodriguez, Paulo C., et al.
Publicado: (2005)

Granulocytic Myeloid-Derived Suppressor Cells in Cystic Fibrosis
por: Tucker, Samantha L., et al.
Publicado: (2021)

Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes
por: Poschke, Isabel, et al.
Publicado: (2013)

Role of myeloid derived suppressor cells in tuberculosis infection and disease
por: Kumar, Nathella Pavan, et al.
Publicado: (2014)

S122: MUTANT IDH1 HIJACKS DIFFERENTIATION PROGRAMS IN MYELOID PROGENITOR CELLS TO IMPAIR GRANULOCYTIC DIFFERENTIATION.
por: Hakobyan, Mariam, et al.
Publicado: (2023)

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity
por: Kramer, Elliot D., et al.
Publicado: (2020)

Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma
por: Ligtenberg, Maarten A., et al.
Publicado: (2018)

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
por: Babačić, Haris, et al.
Publicado: (2020)

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
por: Pillay, Janesh, et al.
Publicado: (2013)

Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
por: Binsfeld, Marilène, et al.
Publicado: (2016)

Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia
por: Ahn, Ari, et al.
Publicado: (2021)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
por: Tallerico, Rossana, et al.
Publicado: (2015)

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
por: Andersson, Emilia, et al.
Publicado: (2015)

Granulocytic myeloid‐derived suppressor cell population increases with the severity of alcoholic liver disease
por: Gao, Miaomiao, et al.
Publicado: (2018)

Increased levels of circulating granulocytic myeloid‑derived suppressor cells in lumbar disc herniation
por: Zhou, Hui, et al.
Publicado: (2023)

Candida-induced granulocytic myeloid-derived suppressor cells are protective against polymicrobial sepsis
por: Esher Righi, Shannon, et al.
Publicado: (2023)

Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes
por: Vonwirth, Verena, et al.
Publicado: (2021)

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg
por: Grimaldi, Antonio M, et al.
Publicado: (2014)

T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma
por: Postow, Michael, et al.
Publicado: (2014)

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
por: Dummer, Reinhard, et al.
Publicado: (2015)

Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage
por: Li, Sha, et al.
Publicado: (2018)

Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
por: Wang, Yungang, et al.
Publicado: (2016)

Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
por: Al-Khami, Amir A, et al.
Publicado: (2015)

Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
por: Liu, Yu-feng, et al.
Publicado: (2018)

Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection
por: Li, Ya-Nan, et al.
Publicado: (2022)

Myeloid Cell-Derived Arginase in Cancer Immune Response
por: Grzywa, Tomasz M., et al.
Publicado: (2020)

The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg
por: Grimaldi, Antonio M, et al.
Publicado: (2013)

P122 Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in rhino-orbital mucormycosis patients
por: Singh, Praveen, et al.
Publicado: (2022)

Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils
por: Fridlender, Zvi G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n2i4e63s430ffjkrpk4itfhnbk